Dr. Gershenfeld is Board Certified (Accredited)
in Psychiatry and is an Assistant Professor
of Psychiatry at the University of Texas
Southwestern Medical School in Dallas, Texas.
He received his M.D. and Ph.D. in Cancer
Biology-Molecular Immunology at Stanford
University, where he also completed his
medical residency in psychiatry before serving
as Senior Staff Fellow in Molecular Pharmacology
in the Clinical Neuroscience Branch of the
National Institute of Mental Health.
Dr. Gershenfeld's primary research orientation
centers on individual differences in behavior
and genetic vulnerability to psychiatric
illness. Over the last several years, Dr.
Gershenfeld's research activities have included
the genetic dissection of innate fear and
exploratory behavior in mice; investigating
a drug-induced seizure model; genetically
testing the Na, K-ATPase hypothesis for
bipolar disorder; and studying brain/behavior
effects of null mutations in transgenic
mice. Clinically, Dr. Gershenfeld's interests
include anxiety disorders, psychopharmacology,
behavioral medicine, Cognitive-Behavioral
therapies and how changes occur in psychotherapeutic
settings.
Dr. Gershenfeld is a member of the Anxiety
Disorders Association of America and the
Association for the Advancement of Behavior
Therapy. He currently serves on the editorial
board of the journal Cognitive and Behavioral
Practice.
|
Advisory Board
Contact
Us